Pre-market hot trades in US stocks: Charles Schwab pre-market up 3.11%
I'm LongbridgeAI, I can summarize articles.Charles Schwab pre-market up 3.11%; Telomir Pharmaceuticals pre-market up 152.07%; MEI Pharma pre-market up 110.44%; Blaize pre-market up 78.22%
Pre-market Hot Trades in US Stocks
Charles Schwab is up 3.11% in pre-market trading. Based on recent important news:
-
On July 18, Charles Schwab announced its second-quarter results, with an average daily trading volume of 7.57 million, exceeding market expectations, driving the stock price up 3.11%.
-
On July 17, Metaplanet announced that Charles Schwab became its second-largest shareholder, holding 61.2 million shares, with a positive market reaction.
-
On July 15, Piper Sandler raised Charles Schwab's target price to $92, boosting market confidence.
Top Gainers in Pre-market US Stocks
Telomir Pharmaceuticals is up 152.07% in pre-market trading. Based on recent important news:
-
On July 17, Telomir Pharmaceuticals released important information through the EDGAR system, leading to increased market interest in its stock, with a pre-market price increase of 152.07%.
-
On July 18, Telomir issued a press release emphasizing the development and commercialization potential of Telomir-1, further driving the stock price up.
-
On July 18, Telomir detailed the risks of its projects and operations in its annual report; nevertheless, the market remains optimistic about its prospects.
MEI Pharma is up 110.44% in pre-market trading. Based on recent key news:
-
On July 18, MEI Pharma released an important announcement via Business Wire, leading to a significant stock price increase of 110.44%.
-
On July 17, positive market expectations for MEI Pharma drove the stock price up.
-
On July 16, industry analysts raised their earnings forecasts for MEI Pharma, further boosting market confidence.
Blaize is up 78.22% in pre-market trading. Based on recent important news:
-
On July 18, Blaize reached a cooperation agreement with Starshine, with a contract value of at least $120 million, driving the stock price up over 90% in pre-market trading.
-
On July 17, Blaize announced that its hybrid AI platform will be deployed in Asia, with the initial phase starting in the third quarter of fiscal year 2025, further enhancing market confidence.
-
On July 18, Blaize projected revenues of at least $35 million in 2025 and at least $130 million in 2026, boosting investor expectations